Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer.

Genes, Chromosomes & Cancer
Lenora W M LooPeggy L Porter

Abstract

The two main histological types of infiltrating breast cancer, lobular (ILC) and the more common ductal (IDC) carcinoma are morphologically and clinically distinct. To assess the molecular alterations associated with these breast cancer subtypes, we conducted a whole-genome study of 166 archival estrogen receptor (ER)-positive tumors (89 IDC and 77 ILC) using the Affymetrix GeneChip(R) Mapping 10K Array to identify sites of loss of heterozygosity (LOH) that either distinguished, or were shared by, the two phenotypes. We found single nucleotide polymorphisms (SNPs) of high-frequency LOH (>50%) common to both ILC and IDC tumors predominately in 11q, 16q, and 17p. Overall, IDC had a slightly higher frequency of LOH events across the genome than ILC (fractional allelic loss = 0.186 and 0.156). By comparing the average frequency of LOH by chromosomal arm, we found IDC tumors with significantly (P < 0.05) higher frequency of LOH on 3p, 5q, 8p, 9p, 20p, and 20q than ILC tumors. We identified additional chromosomal arms differentiating the subtypes when tumors were stratified by tumor size, mitotic rate, or DNA content. Of 5,754 informative SNPs (>25% informativity), we identified 78 and 466 individual SNPs with a higher frequency of L...Continue Reading

References

Jul 30, 1992·The New England Journal of Medicine·J R HarrisW Willett
Jun 1, 1981·American Journal of Clinical Pathology·S M HsuH Fanger
Dec 30, 1994·Biochimica Et Biophysica Acta·P Devilee, C J Cornelisse
Sep 1, 1996·The Journal of Pathology·I P TomlinsonW F Bodmer
May 20, 1998·Journal of the National Cancer Institute·P O'ConnellD C Allred
Feb 20, 2002·JAMA : the Journal of the American Medical Association·Chi-Ling ChenEmily White
Mar 15, 2003·JAMA : the Journal of the American Medical Association·Christopher I LiRoger E Moe
Apr 25, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·H MersinU Berberoğlu
Jun 26, 2003·JAMA : the Journal of the American Medical Association·Christopher I LiJanet R Daling
Mar 23, 2004·Molecular Biology of the Cell·Hongjuan ZhaoStefanie S Jeffrey
Apr 15, 2004·JAMA : the Journal of the American Medical Association·Garnet L AndersonUNKNOWN Women's Health Initiative Steering Committee
Apr 16, 2004·Breast Cancer Research : BCR·Grazia ArpinoRichard M Elledge
Jun 16, 2004·Cancer·E Shelley HwangFrederic M Waldman
Jun 29, 2004·The Journal of Biological Chemistry·Xingzhi XuDavid F Stern
Sep 24, 2004·The Journal of Biological Chemistry·Soma S R Banik, Christopher M Counter
Oct 12, 2004·Biostatistics·Adam B OlshenMichael Wigler
Dec 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Massimo CristofanilliGabriel N Hortobagyi
Mar 17, 2005·Frontiers in Bioscience : a Journal and Virtual Library·Aruna S JaiswalSatya Narayan
Apr 4, 2006·Molecular and Cellular Biology·Eva PetermannKeith W Caldecott
Apr 20, 2006·BMC Cancer·Jane FridlyandDonna G Albertson
Jun 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Lei XuRichard O Hynes
Dec 14, 2006·Advances in Experimental Medicine and Biology·D Ramos, C M Aldaz
Jan 18, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Christopher I LiJanet R Daling

❮ Previous
Next ❯

Citations

Jan 26, 2011·Breast Cancer Research and Treatment·Lenora W M LooPeggy L Porter
May 4, 2012·Applied Immunohistochemistry & Molecular Morphology : AIMM·Xiaoqi LinJan F Silverman
Oct 24, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hiltrud BrauchMichel Eichelbaum
Apr 17, 2012·Human Pathology·Márcia Maria Costa de OliveiraIglenir João Cavalli
Feb 16, 2012·Genes, Chromosomes & Cancer·Bay HoAndrew T Vaughan
Sep 17, 2013·British Journal of Clinical Pharmacology·Hiltrud Brauch, Matthias Schwab
Oct 4, 2014·Clinical Endocrinology·Paul Brennan
Mar 13, 2012·Medical Hypotheses·Marios PoulosAngelos Evangelou
Jan 7, 2014·World Journal of Surgical Oncology·Carlo MolinoUNKNOWN Breast Unit Cardarelli Hospital, Naples, Italy
Sep 26, 2013·Clinical Pharmacology and Therapeutics·M A ProvinceUNKNOWN International Tamoxifen Pharmacogenomics Consortium
Mar 17, 2004·Molecular and Cellular Neurosciences·Michael KlingerClaudia A O Stuermer
Jun 19, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James M RaeMitch Dowsett
Sep 17, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hiltrud BrauchMichel Eichelbaum
Jan 29, 2019·Applied Immunohistochemistry & Molecular Morphology : AIMM·Xiaoqi LinJan F Silverman
Aug 2, 2017·The Pharmacogenomics Journal·G S HwangM V Trivedi
Jul 7, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Mirthe de BoerPaul J van Diest

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.